GSK to receive USD370m and future royalties in CureVac/BioNTech settlement

ViruSure and Oxford Nanopore launch first nanopore-based viral contamination test for biomanufacturing

FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information

Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial

Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine

Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline

Bavarian Nordic chikungunya vaccine enters Health Canada review process

SK bioscience submits IND for Phase 1/2 clinical trial of new influenza vaccine candidate

GC Biopharma secures Vietnamese approval for varicella vaccine BARYCELA

GSK announces submission of RSV vaccine Arexvy for FDA review

PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery

Centivax raises USD45m to commercialise universal flu vaccine

CyanVac's nasal COVID vaccine shows promise in phase 1 trial

hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results

Valneva signs exclusive German vaccine distribution deal with CSL Seqirus